Abstract
1. The burden of stroke worldwide is growing rapidly, driven by an ageing population and by the rapid rate of urbanization and industrialization in the developing world. There are approximately 5 million fatal and 15 million non-fatal strokes each year and over 50 million survivors of stroke alive, worldwide, today. 2. The most important determinant of stroke risk is blood pressure, with a strong, continuous relationship between the level of the systolic and diastolic pressures and the risk of initial and recurrent stroke, in both Western and Asian populations. 3. Randomized clinical trials have clearly demonstrated that blood pressure lowering reduces the risk of initial stroke by 35-40% in hypertensive patients; but, until recently, there was no conclusive evidence that blood pressure lowering was effective in the secondary prevention of stroke. 4. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) has provided definitive evidence that blood pressure lowering in patients with previous stroke or transient ischaemic attack (TIA) reduces the incidence of secondary stroke by 28%, of major vascular events by 26% and of major coronary events by 26%. These reductions were all magnified by approximately 50% in a sub...Continue Reading
References
Sep 1, 1991·British Heart Journal·R J MacFadyenJ L Reid
Mar 31, 1990·Lancet·S MacMahonJ Stamler
Apr 7, 1990·Lancet·R CollinsC H Hennekens
May 1, 1989·Hypertension·S MacMahonJ Stamler
Mar 7, 1970·Lancet·A B Carter
Jul 22, 1974·JAMA : the Journal of the American Medical Association
Apr 1, 1994·British Medical Bulletin·R Collins, S MacMahon
Apr 1, 1993·Stroke; a Journal of Cerebral Circulation
Jul 20, 1996·BMJ : British Medical Journal·A RodgersC Warlow
May 1, 1996·Clinical and Experimental Pharmacology & Physiology·B NealA Rodgers
Apr 1, 1996·Clinical and Experimental Hypertension : CHE
Sep 1, 1996·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·UNKNOWN PROGRESS Management Committee
Mar 1, 1997·Stroke; a Journal of Cerebral Circulation·A G DykerK Lees
May 24, 1997·Lancet·C J Murray, A D Lopez
Sep 23, 1997·Lancet·J A StaessenA Zanchetti
Dec 31, 1997·Stroke; a Journal of Cerebral Circulation·F GueyffierE Schron
Jan 14, 1999·Journal of Hypertension·J Chalmers
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Mar 9, 2000·The New England Journal of Medicine
May 23, 2000·Lancet·M D FlatherE Braunwald
Jul 8, 2000·Stroke; a Journal of Cerebral Circulation·C SartiJ Tuomilehto
Dec 29, 2000·Lancet·B NealUNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration
Apr 11, 2001·Lancet·UNKNOWN EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Oct 9, 2001·Lancet·UNKNOWN PROGRESS Collaborative Group
Dec 4, 2001·Bulletin of the World Health Organization·C D MathersS J Begg
Citations
May 6, 2006·International Journal of Technology Assessment in Health Care·Devidas Menon, Tania Stafinski
Jun 13, 2003·Journal of the American Geriatrics Society·Gustavo C Román
Mar 31, 2009·European Journal of Internal Medicine·B SolunD Dicker
Dec 1, 2004·Stroke; a Journal of Cerebral Circulation·J K McGillI M Macrae
Nov 2, 2018·PloS One·Andrew MitchelmoreJames Faulkner
Oct 27, 2017·Molecular Pharmaceutics·Bayan E AinousahGavin Halbert